Note: Ingredients listed on restricted chemical lists
EC/CAS
50-70-4
Name of the chemical
D-glucitol C6H14O6
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2015-06-01
Product name
Irinotecan Hydrochloride Injection
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
Not applicable
Section 2
Signal word
Not applicable.
Hazard statements
Not applicable.
Precautionary statements
Not applicable. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation, Ingestion, Eye contact, Skin Absorption., Injection.
Potential health effects
Eye Contact with eyes may cause irritation. Skin: Inhalation May cause skin irritation. May cause irritation of respiratory tract. Ingestion May cause irritation. Signs/Symptoms Potential adverse reactions from prescribed doses and overdoses are described in the package insert. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing No medical conditions are known to be aggravated by accidental exposure. Conditions
